{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:05:58Z","timestamp":1789765558215,"version":"4.0.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    Antithrombin (AT) depletion is common in critical illness, and during venovenous extracorporeal membrane oxygenation (VV ECMO), blood\u2013surface interactions further amplify coagulation and inflammation cascades. The prognostic value of baseline AT activity complications at ECMO initiation remains unclear. We conducted a single-center retrospective cohort study of adults receiving VV ECMO (2013\u20132023) to investigate associations between baseline AT activity and bleeding and thrombosis risk. Clinical outcomes included computed tomography (CT)-confirmed ischemic, thrombotic, and bleeding complications and death during ECMO. Analyses included logistic regression, cause-specific Cox models, and unsupervised methods. Among 734 patients, 64% were AT-deficient (&lt; 77%). Antithrombin activity inversely correlated with inflammatory markers. Ischemic complications were more frequent in AT-deficient patients (7.6%\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    1.9%,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    &lt; 0.01), while thrombotic and bleeding rates were similar. Antithrombin activity predicted reduced odds of ischemic events (odds ratio [OR]: 0.97 per 1% increase, 95% confidence interval [CI]: 0.95, 0.98), with an optimal AT threshold of 49 for prediction of ischemic complications (area under the curve [AUC] = 0.74). Three subphenotypes were identified: a consumptive phenotype with markedly reduced AT activity, which carried the highest burden of ischemic complications and mortality. Baseline AT activity and inflammatory status may identify VV ECMO patients at increased risk of ischemia and death, particularly those with a consumptive profile.\n                  <\/jats:p>","DOI":"10.1097\/mat.0000000000002840","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:00:07Z","timestamp":1789765207000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombin Activity and Inflammatory Phenotypes as Predictors of Outcome in Venovenous Extracorporeal Membrane Oxygenation"],"prefix":"10.1097","author":[{"given":"Riccardo","family":"Del Signore","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Giosa","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Fumagalli","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, UK"},{"name":"Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3983-9055","authenticated-orcid":false,"given":"Luigi","family":"Camporota","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, UK"},{"name":"Division of Anaesthetics, Faculty of Medicine, Pain Medicine and Intensive Care (APMIC), Department of Surgery and Cancer, Imperial College London, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"R1-20260918","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin.","volume":"18","author":"Rezaie","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R2-20260918","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/cc4822","article-title":"Molecular mechanism of antithrombin during sepsis.","volume":"10","author":"Wiedermann","year":"2006","journal-title":"Crit Care"},{"key":"R3-20260918","first-page":"15","article-title":"Prognostic value of antithrombin levels in COVID-19 patients and impact of fresh frozen plasma treatment: A retrospective study.","volume":"18","author":"Anakli","year":"2021","journal-title":"Turk J Hematol"},{"key":"R4-20260918","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jtha.2022.11.014","article-title":"Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: Guidance from the scientific and standardization committees on perioperative and critical care hemostasis and thrombosis of the International Society on Thrombosis and Hemostasis.","volume":"21","author":"Helms","year":"2023","journal-title":"J Thromb Haemost"},{"key":"R5-20260918","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.3390\/ijms22084283","article-title":"Antithrombin and its role in host defense and inflammation.","volume":"22","author":"Schl\u00f6mmer","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"R6-20260918","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12055-021-01176-3","article-title":"Anticoagulation in ECMO patients: An overview.","volume":"37","author":"Kumar","year":"2021","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"R7-20260918","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/CCM.0000000000004590","article-title":"A randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation.","volume":"48","author":"Panigada","year":"2020","journal-title":"Crit Care Med"},{"issue":"1_suppl","key":"R8-20260918","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1177\/02676591241237637","article-title":"The role of inflammation and antithrombin supplementation on thromboelastographic parameters during veno-venous ECMO for respiratory failure.","volume":"39","author":"Meli","year":"2024","journal-title":"Perfusion"},{"key":"R9-20260918","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/02676591241258048","article-title":"Antithrombin during veno-venous extracorporeal membrane oxygenation with heparin anticoagulation: A single-center cohort study.","volume":"40","author":"Hileman","year":"2025","journal-title":"Perfusion"},{"key":"R10-20260918","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1051\/ject\/201446084","article-title":"Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation.","volume":"46","author":"Niimi","year":"2014","journal-title":"J Extra Corpor Technol"},{"key":"R11-20260918","doi-asserted-by":"crossref","first-page":"14284","DOI":"10.1038\/s41598-022-17227-7","article-title":"The relationship between antithrombin administration and inflammation during veno-venous ECMO.","volume":"12","author":"Panigada","year":"2022","journal-title":"Sci Rep"},{"key":"R12-20260918","doi-asserted-by":"crossref","first-page":"e2427786","DOI":"10.1001\/jamanetworkopen.2024.27786","article-title":"Antithrombin III levels and outcomes among patients with trauma.","volume":"7","author":"Farrell","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R13-20260918","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.113.003756","article-title":"Mild antithrombin deficiency and risk of recurrent venous thromboembolism: A prospective cohort study.","volume":"129","author":"Di Minno","year":"2014","journal-title":"Circulation"},{"key":"R14-20260918","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13638-021-01910-w","article-title":"A quantitative discriminant method of elbow point for the optimal number of clusters in clustering algorithm.","volume":"2021","author":"Shi","year":"2021","journal-title":"EURASIP J Wirel Commun Netw"},{"key":"R15-20260918","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10985-014-9313-9","article-title":"Checking fine and gray subdistribution hazards model with cumulative sums of residuals.","volume":"21","author":"Li","year":"2015","journal-title":"Lifetime Data Anal"},{"key":"R16-20260918","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/atm.2016.08.62","article-title":"Survival analysis in the presence of competing risks.","volume":"5","author":"Zhang","year":"2017","journal-title":"Ann Transl Med"},{"key":"R17-20260918","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1177\/02676591241279764","article-title":"Acquired antithrombin deficiency in adult patients with postcardiotomy extracorporeal membrane oxygenation.","volume":"40","author":"Cakmak","year":"2025","journal-title":"Perfusion"},{"key":"R18-20260918","doi-asserted-by":"crossref","first-page":"1335826","DOI":"10.3389\/fmed.2024.1335826","article-title":"Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation.","volume":"11","author":"Kim","year":"2024","journal-title":"Front Med"},{"key":"R19-20260918","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00003246-200009001-00008","article-title":"Therapeutic rationale for antithrombin III in sepsis.","volume":"28","author":"Opal","year":"2000","journal-title":"Crit Care Med"},{"key":"R20-20260918","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/SHK.0000000000000727","article-title":"Antithrombin supplementation and mortality in sepsis-induced disseminated intravascular coagulation: A multicenter retrospective observational study.","volume":"46","author":"Hayakawa","year":"2016","journal-title":"Shock"},{"key":"R21-20260918","doi-asserted-by":"crossref","first-page":"A279","DOI":"10.1097\/01.ccm.0000440342.00612.0f","article-title":"1106: The efficacy of antithrombin (AT III) concentrate therapy in severe sepsis.","volume":"41","author":"Yaguchi","year":"2013","journal-title":"Crit Care Med"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MAT.0000000000002840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:00:10Z","timestamp":1789765210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MAT.0000000000002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000002840","relation":{},"ISSN":["1058-2916","1538-943X"],"issn-type":[{"value":"1058-2916","type":"print"},{"value":"1538-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}